CRISPR, tomato

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
CRISPR Therapeutics ( CRSP -5.91%) made a name for itself by pioneering advanced gene therapies made with technologies that didn't exist a generation ago. Now, its challenge is to build on its prior ...
Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA ...
EST Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ...
In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...
Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...
Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...